These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8764690)

  • 1. Protease inhibitors: promising new weapons against HIV.
    Isada CM
    Cleve Clin J Med; 1996; 63(4):204-8. PubMed ID: 8764690
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of HIV proteinase.
    Martin JA; Redshaw S; Thomas GJ
    Prog Med Chem; 1995; 32():239-87. PubMed ID: 8577919
    [No Abstract]   [Full Text] [Related]  

  • 3. Protease inhibitors...the best thing since...?
    Servilio J
    Posit Aware; 1995; ():16-9. PubMed ID: 11362662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ritonavir].
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):281. PubMed ID: 9376397
    [No Abstract]   [Full Text] [Related]  

  • 5. Amprenavir (Agenerase).
    Simmons P
    Res Initiat Treat Action; 1999 Jul; 5(3):7-10. PubMed ID: 11366726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More clinical data on protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):4-7. PubMed ID: 11362917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Darunavir.
    El-Atrouni WI; Temesgen Z
    Drugs Today (Barc); 2007 Oct; 43(10):671-9. PubMed ID: 17987220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV protease inhibitors].
    Rubio R; Romeu J; Viciana P; Redondo C
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():10-4. PubMed ID: 9053020
    [No Abstract]   [Full Text] [Related]  

  • 9. Amprenavir: a new HIV protease inhibitor.
    Med Lett Drugs Ther; 1999 Jul; 41(1057):64-6. PubMed ID: 10436772
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.
    Erickson JW; Gulnik SV; Markowitz M
    AIDS; 1999; 13 Suppl A():S189-204. PubMed ID: 10885776
    [No Abstract]   [Full Text] [Related]  

  • 11. Protease inhibitor update.
    Colvin R; Haas G
    Common Factor; 1995 Apr; (no 10):15. PubMed ID: 11362340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelfinavir (Viracept).
    Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
    [No Abstract]   [Full Text] [Related]  

  • 13. Indinavir (Crixivan).
    Res Initiat Treat Action; 2000 Mar; 6(1):28-9. PubMed ID: 11708184
    [No Abstract]   [Full Text] [Related]  

  • 14. Ritonavir (Norvir).
    Res Initiat Treat Action; 2000 Mar; 6(1):26-7. PubMed ID: 11708183
    [No Abstract]   [Full Text] [Related]  

  • 15. Rescue regimens: the value of protease-inhibitor boosting.
    Segal-Maurer S; Schütz M
    Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
    [No Abstract]   [Full Text] [Related]  

  • 16. Amprenavir (Agenerase).
    Res Initiat Treat Action; 2000 Mar; 6(1):32-3. PubMed ID: 11708186
    [No Abstract]   [Full Text] [Related]  

  • 17. Saquinavir (Fortovase or Invirase).
    Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of HIV-proteinase inhibitors.
    Gazzard B; Moyle G
    Genitourin Med; 1996 Aug; 72(4):233-5. PubMed ID: 8976824
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice.
    Roberts NA; Craig JC; Sheldon J
    AIDS; 1998 Mar; 12(5):453-60. PubMed ID: 9543442
    [No Abstract]   [Full Text] [Related]  

  • 20. Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-1-positive German patients.
    Dietrich U; Raudonat I; Wolf E; Jäger H; Husak R; Orfanos CE; Knickmann M; Knechten H; von Briesen H; Ruppach H; Immelmann A
    AIDS; 1999 Nov; 13(16):2304-5. PubMed ID: 10563717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.